Polpharma passed an inspection by the Food and Drug Administration (FDA). As a result, APIS manufactured by the company gained access to the highly developed US market.
Polpharma Group B.V.COC: Amsterdam nr. 33250246
© Polpharma Group B.V. 2023. All rights reserved.
Herengracht 480, 1017 CB Amsterdam, The Netherlands+31 (0)20 705 4800